These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 30272185)
1. Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis. Tamhane S; Rodriguez-Gutierrez R; Iqbal AM; Prokop LJ; Bancos I; Speiser PW; Murad MH J Clin Endocrinol Metab; 2018 Nov; 103(11):4097-4103. PubMed ID: 30272185 [TBL] [Abstract][Full Text] [Related]
2. Epicardial Fat Thickness in Children with Classic Congenital Adrenal Hyperplasia. Metwalley KA; Farghaly HS; Abdelhamid A J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):61-69. PubMed ID: 30282618 [TBL] [Abstract][Full Text] [Related]
3. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature. Ahmed SEAM; Soliman AT; Ramadan MA; Elawwa A; Abugabal AMS; Emam MHA; De Sanctis V Acta Biomed; 2019 Sep; 90(3):360-369. PubMed ID: 31580328 [TBL] [Abstract][Full Text] [Related]
4. Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Paizoni L; Auer MK; Schmidt H; Hübner A; Bidlingmaier M; Reisch N J Steroid Biochem Mol Biol; 2020 Mar; 197():105540. PubMed ID: 31730799 [TBL] [Abstract][Full Text] [Related]
5. Long-term cardio-metabolic outcomes in patients with classical congenital adrenal hyperplasia: is the risk real? Gomes LG; Mendonca BB; Bachega TASS Curr Opin Endocrinol Diabetes Obes; 2020 Jun; 27(3):155-161. PubMed ID: 32304389 [TBL] [Abstract][Full Text] [Related]
7. Ambulatory blood pressure and subclinical cardiovascular disease in patients with congenital adrenal hyperplasia: a preliminary report. Akyürek N; Atabek ME; Eklioğlu BS; Alp H J Clin Res Pediatr Endocrinol; 2015 Mar; 7(1):13-8. PubMed ID: 25800471 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk in Cuban adolescents and young adults with congenital adrenal hyperplasia. Espinosa Reyes TM; Pesántez Velepucha AK; Cabrera Rego JO; Valdés Gómez W; Domínguez Alonso E; Falhammar H BMC Endocr Disord; 2023 Nov; 23(1):241. PubMed ID: 37919699 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia. Torky A; Sinaii N; Jha S; Desai J; El-Maouche D; Mallappa A; Merke DP J Clin Endocrinol Metab; 2021 Nov; 106(12):e5247-e5257. PubMed ID: 33677504 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Sartorato P; Zulian E; Benedini S; Mariniello B; Schiavi F; Bilora F; Pozzan G; Greggio N; Pagnan A; Mantero F; Scaroni C J Clin Endocrinol Metab; 2007 Mar; 92(3):1015-8. PubMed ID: 17200174 [TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia. Barbot M; Mazzeo P; Lazzara M; Ceccato F; Scaroni C Front Endocrinol (Lausanne); 2022; 13():934675. PubMed ID: 35979433 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia. Marra AM; Improda N; Capalbo D; Salzano A; Arcopinto M; De Paulis A; Alessio M; Lenzi A; Isidori AM; Cittadini A; Salerno M J Clin Endocrinol Metab; 2015 Feb; 100(2):644-52. PubMed ID: 25405496 [TBL] [Abstract][Full Text] [Related]
13. Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia. Amr NH; Ahmed AY; Ibrahim YA J Endocrinol Invest; 2014 Oct; 37(10):1001-8. PubMed ID: 25112902 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Kim MS; Merke DP Semin Reprod Med; 2009 Jul; 27(4):316-21. PubMed ID: 19530065 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors and increased carotid intima-media thickness in young patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Rodrigues TM; Barra CB; Santos JL; Goulart EM; Ferreira AV; Silva IN Arch Endocrinol Metab; 2015 Dec; 59(6):541-7. PubMed ID: 26677089 [TBL] [Abstract][Full Text] [Related]
16. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Völkl TM; Simm D; Beier C; Dörr HG Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852 [TBL] [Abstract][Full Text] [Related]